Novel insights into molecular mechanisms of abruption-induced preterm birth

Expert Reviews in Molecular Medicine

Volumn 12, Issue , 2010, Pages

  Buhimschi, Catalin S ^a   Schatz, Frederik ^a   Krikun, Graciela ^a   Buhimschi, Irina A ^a   Lockwood, Charles J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; PROGESTERONE; THROMBIN; THROMBOPLASTIN;

ADAPTIVE IMMUNITY; CYTOKINE RELEASE; DECIDUA; FETUS MEMBRANE; FETUS RISK; FIBRINOLYSIS; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HIGH RISK PREGNANCY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOLUTIO PLACENTAE; THROMBOPLASTIN GENE; TRANSGENIC MOUSE; UPREGULATION; VASCULAR ENDOTHELIUM; BLEEDING; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; PREGNANCY; PREMATURITY; SIGNAL TRANSDUCTION;

ABRUPTIO PLACENTAE; FEMALE; HEMORRHAGE; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY; PREMATURE BIRTH; SIGNAL TRANSDUCTION;

EID: 79952110096     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399410001675     Document Type: Review

References (132)

1. Stoll, B.J. et al. (2004) National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Journal of the American Medical Association 292, 2357-2365 (Pubitemid 39491920)
2. Zerhouni, E.A. (2005) US biomedical research: basic, translational, and clinical sciences. Journal of the American Medical Association 294, 1352-1358
3. Fagnan, L.J. (2010) Linking practice-based research networks and clinical and translational science awards: new opportunities for community engagement by academic health centers. Academic Medicine 85, 476-483
4. McLean, M. et al. (1995) A placental clock controlling the length of human pregnancy. Nature Medicine 1, 460-463
5. Zenclussen, A.C. et al. (2007) Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus. Expert Reviews in Molecular Medicine 9, 1-14 (Pubitemid 47108089)
6. Mendelson, C.R. (2009) Minireview: fetal-maternal hormonal signaling in pregnancy and labor. Molecular Endocrinology 23, 947-954
7. Muglia, L.J. and Katz, M. (2010) The enigma of spontaneous preterm birth. New England Journal of Medicine 362, 529-535
8. Buhimschi, C.S. et al. (2008) Multidimensional system biology: genetic markers and proteomic biomarkers of adverse pregnancy outcome in preterm birth. American Journal of Perinatology 25, 175-187 (Pubitemid 351429730)
9. Lockwood, C.J. and Kuczynski, E. (2001) Risk stratification and pathological mechanisms in preterm delivery. Paediatric and Perinatal Epidemiology 2, 78-89 (Pubitemid 33719620)
10. Anum, E.A. et al. (2009) Genetic contributions to disparities in preterm birth. Pediatric Research 65, 1-9
11. Challis, J.R. et al. (2009) Inflammation and pregnancy. Reproductive Sciences 16, 206-215
12. Norman, J.E. et al. (2007) Inflammatory pathways in the mechanism of parturition. BMC Pregnancy Childbirth 7 (Suppl 1), S7
13. Weiner, C.P. et al. (2010) Human effector/initiator gene sets that regulate myometrial contractility during term and preterm labor. American Journal of Obstetrics and Gynecology 202, 474.e1-474.e20
14. Hall, D.R. (2009) Abruptio placentae and disseminated intravascular coagulopathy. Seminars in Perinatology 33, 189-195
15. Elsasser, D.A. et al. (2010) Diagnosis of placental abruption: relationship between clinical and histopathological findings. European Journal of Obstetrics, Gynecology, and Reproductive Biology 148, 125-130
16. Ananth, C.V. et al. (2005) Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. American Journal of Obstetrics and Gynecology 192, 191-198 (Pubitemid 40164241)
17. Ananth, C.V. et al. (1999) Placental abruption and adverse perinatal outcomes. Journal of the American Medical Association 282, 1646-1651 (Pubitemid 29513971)
18. Oyelese, Y. and Ananth, C.V. (2006) Placental abruption. Obstetrics and Gynecology 108, 1005-1016 (Pubitemid 44498264)
19. Ananth, C.V. and Wilcox, A.J. (2001) Placental abruption and perinatal mortality in the United States. American Journal of Epidemiology 153, 332-337 (Pubitemid 32144558)
20. Salafia, C.M. et al. (1995) Histologic evidence of old intrauterine bleeding is more frequent in prematurity. American Journal of Obstetrics and Gynecology 173, 1065-1070
21. Lockwood, C.J. (2006) Pregnancy-associated changes in the hemostatic system. Clinical Obstetrics and Gynecology 49, 836-843
22. Benirschke, K. (1994) Anatomical relationship between fetus and mother. Annals of the New York Academy of Sciences 731, 9-20
23. Dommisse, J. and Tiltman, A.J. (1992) Placental bed biopsies in placental abruption. British Journal of Obstetrics and Gynaecology 99, 651-654
24. Nath, C.A. et al. (2007) Histologic evidence of inflammation and risk of placental abruption. New Jersey-placental abruption study investigators. American Journal of Obstetrics and Gynecology 197, 319.e1-319.e6
25. Arias, F. et al. (1993) Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. American Journal of Obstetrics and Gynecology 168, 585-591 (Pubitemid 23069118)
26. Pober, J.S. and Sessa, W.C. (2007) Evolving functions of endothelial cells in inflammation. Nature Reviews. Immunology 7, 803-815 (Pubitemid 47480307)
27. Kumar, P. et al. (2009) Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Reviews in Molecular Medicine 11, e19
28. Reznik, S.E. et al. (1998) Immunohistochemical localization of carboxypeptidases E and D in the human placenta and umbilical cord. Journal of Histochemistry and Cytochemistry 46, 1359-1368
29. Liu, J. et al. (2009) Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. FEBS Journal 276, 4598-4606
30. Pinheiro da Silva, F. and Soriano, F.G. (2009) Neutrophils recruitment during sepsis: critical points and crossroads. Frontiers in Bioscience 14, 4464-4476
31. Ley, K. and Reutershan, J. (2006) Leucocyte-endothelial interactions in health and disease. Handbook of Experimental Pharmacology 176, 97-133
32. Levi, M. and van der Poll, T. (2010) Inflammation and coagulation. Critical Care Medicine 38, S26-S34
33. Bach, R., Nemerson, Y. and Konigsberg, W. (1981) Purification and characterization of bovine tissue factor. Journal of Biological Chemistry 256, 8324-8331
34. Spicer, E.K. et al. (1987) Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proceedings of the National Academy of Sciences of the United States of America 84, 5148-5152 (Pubitemid 17119118)
35. Polgar, J., Matuskova, J. and Wagner, D.D. (2005) The P-selectin, tissue factor, coagulation triad. Journal of Thrombosis and Haemostasis 3, 1590-1596 (Pubitemid 41716543)
36. Moll, T. et al. (1995) Regulation of the tissue factor promoter in endothelial cells. Journal of Biological Chemistry 270, 3849-3857
37. Rao, L.V. and Mackman, N. (2010) Factor VIIa and tissue factor - from cell biology to animal models. Thrombosis Research 125 (Suppl 1), S1-S3
38. Popescu, N.I., Lupu, C. and Lupu, F. (2010) Role of PDI in regulating tissue factor: FVIIa activity. Thrombosis Research 125 (Suppl 1), S38-S41
39. Mackman, N. (2009) The many faces of tissue factor. Journal of Thrombosis and Haemostasis 1, 136-139
40. Krikun, G., Lockwood, C.J. and Paidas, M.J. (2009) Tissue factor and the endometrium: from physiology to pathology. Thrombosis Research 124, 393-396
41. Rao, L.V., Pendurthi, U.R. (2003) Regulation of tissue factor-factor VIIa expression on cell surfaces: a role for tissue factor-factor VIIa endocytosis. Molecular and Cellular Biochemistry 253, 131-140 (Pubitemid 37321719)
42. Aharon, A. et al. (2004) Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thrombosis and Haemostasis 92, 776-786 (Pubitemid 39386704)
43. Drake, T.A., Morrissey, J.H. and Edgington, T.S. (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. American Journal of Pathology 134, 1087-1097 (Pubitemid 19142892)
44. Stassen, J.M., Arnout, J. and Deckmyn, H. (2004) The hemostatic system. Current Medical Chemistry 11, 2245-2260 (Pubitemid 39172347)
45. Lockwood, C.J. et al. (1991) Amniotic fluid contains tissue factor, a potent initiator of coagulation. American Journal of Obstetrics and Gynecology 165, 1335-1341
46. Lockwood, C.J. et al. (2009) Progestin and thrombin regulate tissue factor expression in human term decidual cells. Journal of Clinical Endocrinology and Metabolism 94, 2164-2170
47. Lockwood, C.J. et al. (1993) Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. Journal of Clinical Endocrinology and Metabolism 76, 231-236 (Pubitemid 23027585)
48. Schatz, F. et al. (2003) Progestin-regulated expression of tissue factor in decidual cells: implications in endometrial hemostasis, menstruation and angiogenesis. Steroids 68, 849-860 (Pubitemid 37532409)
49. Lockwood, C.J. et al. (2000) Progestin-epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells. Journal of Clinical Endocrinology and Metabolism 85, 297-301 (Pubitemid 32268829)
50. Erlich, J. et al. (1999) Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proceedings of the National Academy of Sciences of the United States of America 96, 8138-8143 (Pubitemid 29328421)
51. Bergh, N. et al. (2009) Influence of TNF-alpha and biomechanical stress on endothelial anti- and prothrombotic genes. Biochemical and Biophysical Research Communications 385, 314-318
52. Mertens, G. et al. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. Journal of Biological Chemistry 267, 20435-20443
53. Jackson, C.J. and Xue, M. (2008) Activated proteinC - an anticoagulant that does more than stop clots. International Journal of Biochemistry and Cell Biology 40, 2692-2697
54. Castellino, F.J. and Ploplis, V.A. (2009) The protein C pathway and pathologic processes. Journal of Thrombosis and Haemostasis 7 (Suppl 1), 140-145
55. Ignarro, L.J. (1989) Endothelium-derived nitric oxide: actions and properties. FASEB Journal 3, 31-36
56. Harris, L.K. (2008) Trophoblast-derived heparanase is not required for invasion. Placenta 29, 332-337
57. Dempsey, L.A. et al. (2000) Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 10, 467-475 (Pubitemid 30216088)
58. Meeusen, E.N., Bischof, R.J. and Lee, C.S. (2001) Comparative T-cell responses during pregnancy in large animals and humans. American Journal of Reproductive Immunology 46, 169-179 (Pubitemid 32691200)
59. Martinon, F., Mayor, A. and Tschopp, J. (2009) The inflammasomes: guardians of the body. Annual Review of Immunology 27, 229-265
60. Reddy, R.C. et al. (2001) Sepsis-induced immunosuppression: from bad to worse. Immunologic Research 24, 273-287 (Pubitemid 33064386)
61. Cinel, I. and Opal, S.M. (2009) Molecular biology of inflammation and sepsis: a primer. Critical Care Medicine 37, 291-304
62. Benhamou, Y. et al. (2009) Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice. Critical Care Medicine 37, 1724-1728
63. Arcuri, F. et al. (2009) Mechanisms of leukocyte accumulation and activation in chorioamnionitis: interleukin 1 beta and tumor necrosis factor alpha enhance colony stimulating factor 2 expression in term decidua. Reproductive Sciences 16, 453-461
64. Lockwood, C.J. et al. (2008) Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biology of Reproduction 78, 1064-1072 (Pubitemid 351749303)
65. Buhimschi, I.A. et al. (1998) The nitric oxide pathway in pre-eclampsia: pathophysiological implications. Human Reproduction Update 4, 25-42 (Pubitemid 28223053)
66. Lee, S. et al. (2008) The interleukin-6 (IL-6) trans-signaling system: evidence for presence and activation in pregnancies complicated by intra-amniotic infection. American Journal of Obstetrics and Gynecology 199, S141. Presented at the Society for Maternal Fetal Medicine 2009 (26-31 January 2009; San Diego, CA, USA)
67. Buhimschi, I.A. et al. (2007) The receptor for advanced glycation end products (RAGE) system in women with intra-amniotic infection and inflammation. American Journal of Obstetrics and Gynecology 196, e1-e13
68. Dunk, C. et al. (2000) Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. American Journal of Pathology 156, 2185-2199 (Pubitemid 30641785)
69. Ahmed, A. et al. (1997) Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Laboratory Investigation 76, 779-791 (Pubitemid 27260345)
70. Holmlund, U. et al. (2007) The novel inflammatory cytokine high mobility group box protein 1 (HMGB1) is expressed by human term placenta. Immunology 122, 430-437 (Pubitemid 47556480)
71. Buhimschi, C.S. et al. (2010) Amniotic fluid angiopoietin-1, angiopoietin-2, and soluble receptor Tie2 levels and regulation in normal pregnancy and intra-amniotic inflammation induced preterm birth. Journal of Clinical Endocrinology and Metabolism 95, 3428-3436
72. Bulmer, J.N., Williams, P.J. and Lash, G.E. (2010) Immune cells in the placental bed. International Journal of Developmental Biology 54, 281-294
73. Mantovani, A. et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 25, 677-686 (Pubitemid 39457982)
74. Gustafsson, C. et al. (2008) Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 3, e2078
75. Pétrilli, V. et al. (2007) The inflammasome: a danger sensing complex triggering innate immunity. Current Opinion in Immunology 19, 615-622 (Pubitemid 350236810)
76. Buhimschi, C.S. et al. (2009) Characterization of RAGE, HMGB1, and S100beta in inflammation-induced preterm birth and fetal tissue injury. American Journal of Pathology 175, 958-975
77. Kimbrell, D.A. and Beutler, B. (2001) The evolution and genetics of innate immunity. Nature Reviews. Genetics 2, 256-267 (Pubitemid 33674774)
78. Medzhitov, R. (2007) Recognition of microorganisms and activation of the immune response. Nature 449, 819-826
79. Buhimschi, I.A., Christner, R. and Buhimschi, C.S. (2005) Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 112, 173-181 (Pubitemid 40188245)
80. Buhimschi, I.A. et al. (2008) Multidimensional proteomics analysis of amniotic fluid to provide insight into the mechanisms of idiopathic preterm birth. PLoS One 23, 3, e2049
81. Cakmak, H. et al. (2005) Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery. Journal of Clinical Endocrinology and Metabolism 90, 5279-5286 (Pubitemid 41262286)
82. Buhimschi, C.S. and Buhimschi, I.A. (2007) Proteomic biomarkers of adverse pregnancy outcome in preterm birth - a theranostics opportunity. Future drugs - expert review. Obstetrics and Gynecology 2, 743-753
83. Lockwood, C.J. et al. (2005) Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. American Journal of Pathology 167, 1443-1449 (Pubitemid 41541429)
84. Krikun, G. et al. (2007) Expression of Toll-like receptors in the human decidua. Histology and Histopathology 22, 847-854 (Pubitemid 47034150)
85. Koga, K. and Mor, G. (2008) Expression and function of toll-like receptors at the maternal-fetal interface. Reproductive Sciences 15, 231-242 (Pubitemid 351550944)
86. Buhimschi, C.S. et al. (2009) Insight into innate immunity of the uterine cervix as a host defense mechanism against infection and preterm birth. Expert Review of Obstetrics and Gynecology 4, 9-15
87. van Zoelen, M.A. et al. (2009) Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31, 280-284
88. Cohen, M.J. et al. (2009) Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Critical Care 13, R174
89. Ananth, C.V. et al. (2004) Preterm premature rupture of membranes, intrauterine infection, and oligohydramnios: risk factors for placental abruption. Obstetrics and Gynecology 2004, 104, 71-77 (Pubitemid 40458907)
90. Lockwood, C.J. et al. (2009) Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption. Thrombosis Research 124, 516-520
91. Esmon, C.T. (2008) Crosstalk between inflammation and thrombosis. Maturitas 61, 122-131
92. Taylor, F.B. Jr. et al. (1984) A model for thrombin protection against endotoxin. Thrombosis Research 36, 177-185
93. Rosen, T. et al. (2001) Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. Journal of Maternal-Fetal and Neonatal Medicine 10, 297-300
94. Fiedler, U. and Augustin, H.G. (2006) Angiopoietins: a link between angiogenesis and inflammation. Trends in Immunology 27, 552-558 (Pubitemid 44780853)
95. Krikun, G. et al. (2007) Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thrombosis and Haemostasis 97, 245-253 (Pubitemid 46592145)
96. Lockwood, C.J. et al. (2007) Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. American Journal of Pathology 170, 1398-1405 (Pubitemid 47339346)
97. Goldman-Wohl, D. and Yagel, S. (2002) Regulation of trophoblast invasion: from normal implantation to pre-eclampsia. Molecular and Cellular Endocrinology 187, 233-238 (Pubitemid 34436953)
98. Krikun, G. et al. (2004) Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. American Journal of Pathology 164, 2101-2107 (Pubitemid 38669357)
99. Chaudhari, B.P. et al. (2008) The genetics of birth timing: insights into a fundamental component of human development. Clinical Genetics 74, 493-501
100. Nesin, M. (2007) Genetic basis of preterm birth. Frontiers in Bioscience 12, 115-124
101. Rasmussen, S., Irgens, L.M. and Dalaker, K. (1997) The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. British Journal of Obstetrics and Gynaecology 104, 1292-1295 (Pubitemid 27485498)
102. Peltier, M.R. (2009) Thromboembolic diseases in families of women with placental abruption. Epidemiology 20, 733-737
103. Rasmussen, S. and Irgens, L.M. (2009) Occurrence of placental abruption in relatives. BJOG 116, 693-699
104. Kinzler, W.L. et al. (2009) The effect of maternal thrombophilia on placental abruption: histologic correlates. Journal of Maternal-Fetal and Neonatal Medicine 22, 243-248
105. van der Molen, E.F. et al. (2000) A common mutation in the 5,10-methylenetetrahydro-folate reductase gene as a new risk factor for placental vasculopathy. American Journal of Obstetrics and Gynecology 182, 1258-1263
106. Procházka, M. (2003) Factor V Leiden in pregnancies complicated by placental abruption. BJOG 110, 462-466
107. Jaaskelainen, E. et al. (2008) Polymorphism of the interleukin 1 receptor antagonist (IL1Ra) gene and placental abruption. Journal of Reproductive Immunology 79, 58-62
108. Ananth, C.V. et al. (2007) Associations between 2 polymorphisms in the methylene-tetrahydrofolate reductase gene and placental abruption. American Journal of Obstetrics and Gynecology 197, 385.e1-385.e7
109. Zdoukopoulos, N. and Zintzaras, E. (2008) Genetic risk factors for placental abruption: aHuGE review and meta-analysis. Epidemiology 19, 309-323 (Pubitemid 351253023)
110. Said, J.M. et al. (2010) Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstetrics and Gynecology 115, 5-13
111. Silver, R.M. et al. (2010) Prothrombin gene G20210A mutation and obstetric complications. Obstetrics and Gynecology 115, 14-20
112. Anteby, E.Y. et al. (2004) Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption. European Journal of Obstetrics, Gynecology, and Reproductive Biology 113, 31-35 (Pubitemid 38281191)
113. Redline, R.W. and Pappin, A. (1995) Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Human Pathology 26, 80-85
114. Smith, R. (2007) Parturition. New England Journal of Medicine 356, 271-283
115. Csapo, A. (1956) Progesterone "block." American Journal of Anatomy 98, 273-292
116. Tita, A.T. and Rouse, D.J. (2009) Progesterone for preterm birth prevention: an evolving intervention. American Journal of Obstetrics and Gynecology 200, 219-224
117. Mesiano, S. and Welsh, T.N. (2007) Steroid hormone control of myometrial contractility and parturition. Seminars in Cell and Developmental Biology 18, 321-331 (Pubitemid 47211985)
118. Merlino, A. et al. (2009) Nuclear progesterone receptor expression in the human fetal membranes and decidua at term before and after labor. Reproductive Science 16, 357-363
119. Schatz, F. and Lockwood, C.J. (1993) Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. Journal of Clinical Endocrinology and Metabolism 77, 621-625 (Pubitemid 23298637)
120. Krikun, G. et al. (1998) Transcriptional regulation of the tissue factor gene by progestins in human endometrial stromal cells. Journal of Clinical Endocrinology and Metabolism 83, 926-930 (Pubitemid 28496469)
121. Krikun, G. et al. (2000) Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3. Molecular Endocrinology 14, 393-400 (Pubitemid 32260531)
122. Norwitz, E.R. et al. (2007) Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition. American Journal of Obstetrics and Gynecology 196, 382.e1-382.e8
123. Lockwood, C.J. (1994) Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content. Journal of Clinical Endocrinology and Metabolism 79, 786-790
124. Lockwood, C.J. et al. (1998) Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal. Endocrinology 139, 4607-4613 (Pubitemid 28487779)
125. Schatz, F. et al. (1999) Implications of decidualization-associated protease expression in implantation and menstruation. Seminars in Reproductive Endocrinology 17, 3-12 (Pubitemid 29293547)
126. Christiaens, I. et al. (2008) Inflammatory processes in preterm and term parturition. Journal of Reproductive Immunology 79, 50-57
127. Trepicchio, W.L. et al. (1996) Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. Journal of Immunology 157, 3627-3634 (Pubitemid 126449177)
128. Anum, E.A. et al. (2009) Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity. Placenta 30, 207-215
129. Parry, S., Strauss, J.F., III (1998) Premature rupture of the fetal membranes. New England Journal of Medicine 338, 663-670 (Pubitemid 28108437)
130. Rosen, T. et al. (2002) Thrombin-enhanced matrix metalloproteinase-1 expression: a mechanism linking placental abruption with premature rupture of the membranes. Journal of Maternal-Fetal and Neonatal Medicine 11, 11-17
131. Stephenson, C.D. et al. (2005) Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. Journal of Maternal-Fetal and Neonatal Medicine 18, 17-22 (Pubitemid 41224358)
132. Buhimschi, I.A. et al. (2000) Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes. American Journal of Obstetrics and Gynecology 182, 458-464 (Pubitemid 30127363)